Chest
Volume 154, Issue 3, September 2018, Pages 645-652
Journal home page for Chest

Translating Basic Research Into Clinical Practice
Advances in the Genetics of Primary Ciliary Dyskinesia: Clinical Implications

https://doi.org/10.1016/j.chest.2018.05.007Get rights and content

Primary ciliary dyskinesia is a rare genetic disease of the motile cilia and is one of a rapidly expanding collection of disorders known as ciliopathies. Patients with primary ciliary dyskinesia have diverse clinical manifestations, including chronic upper and lower respiratory tract disease, left-right laterality defects, and infertility. In recent years, our understanding of the genetics of primary ciliary dyskinesia has rapidly advanced. A growing number of disease-associated genes and pathogenic mutations have been identified, which encode axonemal, cytoplasmic, and regulatory proteins involved in the assembly, structure, and function of motile cilia. Our knowledge of cilia genetics and the function of the proteins encoded has led to a greater understanding of the clinical manifestations of motile ciliopathies. These advances have changed our approach toward diagnostic testing for primary ciliary dyskinesia. In this review, we will describe how new insights into genetics have allowed us to define the clinical features of primary ciliary dyskinesia, revolutionize diagnostics, and reveal previously unrecognized genotype-phenotype relationships in primary ciliary dyskinesia.

Key Words

axoneme
bronchiectasis
cilia
ciliopathy
mucociliary clearance

Abbreviations

PCD
primary ciliary dyskinesia

Cited by (0)

FUNDING/SUPPORT: The authors received support from the National Institutes of Health (NIH) [Grants HL096458, HL116211 to T. W. F.], National Health and Medical Research Council [Grant NHMRC1043768 to T. W. F.], American Thoracic Society Foundation-PCD Foundation-Kovler Family Foundation Partner Research Award [to A. H.], and the Washington University Children’s Discovery Institute. The Genetic Disorders of Mucociliary Clearance Consortium [HL096458] is part of the NIH Rare Disease Clinical Research Network, supported through collaboration between the NIH Office of Rare Diseases Research at the National Center for Advancing Translational Science and the National Heart, Lung and Blood Institute.

View Abstract